Skip to content

Non-Invasive Deep Brain Stimulation (Transcranial Transient Interference Stimulation, tTIS) on Improving Cognitive Function in Alzheimer's Disease:An Exploratory Study

Non-Invasive Deep Brain Stimulation (Transcranial Transient Interference Stimulation, tTIS) on Improving Cognitive Function in Alzheimer's Disease:An Exploratory Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117062
Enrollment
Unknown
Registered
2026-01-19
Start date
2026-01-20
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimers disease

Interventions

Transcranial time-domain interference electrical stimulation (tTIS) group:Transcranial time-domain interference electrical stimulation

Sponsors

The First Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Meets the NIA-AA (2018) published AD diagnosis criteria; 2.Ages between 60-80, gender not specified; 3.Clinical Dementia Rating Scale (CDR) initial screening score of 0.5 or 1; 4.The patients can communicate normally and complete the scales involved in the study independently. 5.Biomarker positive; 6.Voluntarily participate in the research with full understanding of the research content, process, and potential risks, and jointly sign the written informed consent approved by the ethics with the guardian;

Exclusion criteria

Exclusion criteria: 1.Merged with other neurological, psychiatric, or brain diseases, etc; 2.History of previous brain surgery; 3.Patients with epilepsy, severe cognitive dysfunction and inability to cooperate; 4.Those with a history of psychosis or communication disorders; 5.Contraindications to MRI or tTIS, such as metal implants, pacemakers, claustrophobia, and incomplete skull; 6.Investigators who have participated in other clinical trials;

Design outcomes

Primary

MeasureTime frame
Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog);

Secondary

MeasureTime frame
Instrumental activities of daily living;Neuroimaging evaluation of near-infrared non-invasive cerebral function detection;Montreal Cognitive Assessment;Incidence of adverse events;Mini-Mental State Examination;Neuropsychiatric symptom questionnaire;Self-care ability assessment in daily life;

Countries

China

Contacts

Public ContactJingming Hou

The First Affiliated Hospital of Army Medical University

jingminghou@hotmail.com+86 23 6876 6388

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026